PRTN3 and rheumatoid arthritis: At diagnosis onset, a typical RA patient presents with joint inflammation assessed clinically, by ultrasound or MRI (EULAR/ACR RA classification criteria 2010 [4]), and autoantibodies against different types of post-translationally modified proteins, such as ACPA and rheumatoid factor (RF).